Fus and tardbp but not sod1 interact in genetic models of amyotrophic lateral sclerosis

PLoS Genetics

Volumn 7, Issue 8, 2011, Pages

  Kabashi, Edor ^a,b,c   Bercier, Valérie ^a,b   Lissouba, Alexandra ^a   Liao, Meijiang ^a   Brustein, Edna ^a   Rouleau, Guy A ^a,b   Drapeau, Pierre ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE MORPHOLINO OLIGONUCLEOTIDE; ANTISENSE OLIGONUCLEOTIDE; COPPER ZINC SUPEROXIDE DISMUTASE; FUSED IN SARCOMA PROTEIN; MESSENGER RNA; RNA BINDING PROTEIN; TAR DNA BINDING PROTEIN; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; PROTEIN TDP-43; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; COPPER ZINC SUPEROXIDE DISMUTASE GENE; EMBRYO; ESCAPE BEHAVIOR; EVOKED RESPONSE; FUSED IN SARCOMA GENE; GAIN OF FUNCTION MUTATION; GENE; GENE INTERACTION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC MODEL; GENETIC POLYMORPHISM; GENOME; HUMAN; IN SITU HYBRIDIZATION; IN VIVO STUDY; LOSS OF FUNCTION MUTATION; MOTONEURON; NERVE PROJECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHENOTYPE; PROTEIN EXPRESSION; TAR DNA BINDING PROTEIN GENE; TOXIC GAIN OF FUNCTION MUTATION; TRANSLATION INITIATION; WILD TYPE; ZEBRA FISH; ANIMAL; BIOLOGICAL MODEL; GENETIC EPISTASIS; GENETICS; METABOLISM; MOTOR ACTIVITY; MUTATION;

DANIO RERIO;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DNA-BINDING PROTEINS; EPISTASIS, GENETIC; HUMANS; MODELS, GENETIC; MOTOR ACTIVITY; MUTATION; PHENOTYPE; RNA-BINDING PROTEIN FUS; SUPEROXIDE DISMUTASE; ZEBRAFISH;

EID: 80052374038     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1002214     Document Type: Article

References (73)

1. Nelson LM, (1995) Epidemiology of ALS. Clin Neurosci 3: 327-331.
2. Boillee S, Van de Velde C, Cleveland DW, (2006) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52: 39-59.
3. Gros-Louis F, Gaspar C, Rouleau GA, (2006) Genetics of familial and sporadic amyotrophic lateral sclerosis. Biochim Biophys Acta.
4. Pasinelli P, Brown RH, (2006) Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci 7: 710-723.
5. Rosen DR, (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 364: 362.
6. Kabashi E, Valdmanis PN, Dion P, Rouleau GA, (2007) Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis? Ann Neurol 62: 553-559.
7. Bendotti C, Carri MT, (2004) Lessons from models of SOD1-linked familial ALS. Trends Mol Med 10: 393-400.
8. Lemmens R, Van Hoecke A, Hersmus N, Geelen V, D'Hollander I, et al. (2007) Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish. Hum Mol Genet 16: 2359-2365.
9. Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, et al. (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40: 572-574.
10. Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, et al. (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319: 1668-1672.
11. Lagier-Tourenne C, Cleveland DW, (2009) Rethinking ALS: the FUS about TDP-43. Cell 136: 1001-1004.
12. Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, et al. (2008) TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol 63: 535-538.
13. Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, et al. (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323: 1208-1211.
14. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, et al. (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323: 1205-1208.
15. Lagier-Tourenne C, Polymenidou M, Cleveland DW, TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet 19: R46-64.
16. Mackenzie IR, Rademakers R, Neumann M, TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol 9: 995-1007.
17. Blair IP, Williams KL, Warraich ST, Durnall JC, Thoeng AD, et al. (2009) FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis. J Neurol Neurosurg Psychiatry.
18. Corrado L, Del Bo R, Castellotti B, Ratti A, Cereda C, et al. (2009) Mutations of FUS Gene in Sporadic Amyotrophic Lateral Sclerosis. J Med Genet.
19. Belzil VV, Valdmanis PN, Dion PA, Daoud H, Kabashi E, et al. (2009) Mutations in FUS cause FALS and SALS in French and French Canadian populations. Neurology 73: 1176-1179.
20. Chio A, Restagno G, Brunetti M, Ossola I, Calvo A, et al. (2009) Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutation. Neurobiol Aging 30: 1272-1275.
21. Ticozzi N, Silani V, LeClerc AL, Keagle P, Gellera C, et al. (2009) Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort. Neurology 73: 1180-1185.
22. Chio A, Calvo A, Moglia C, Ossola I, Brunetti M, et al. (2010) A de novo missense mutation of the FUS gene in a "true" sporadic ALS case. Neurobiol Aging.
23. Yan J, Deng HX, Siddique N, Fecto F, Chen W, et al. (2010) Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia. Neurology 75: 807-814.
24. Millecamps S, Salachas F, Cazeneuve C, Gordon P, Bricka B, et al. (2010) SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J Med Genet 47: 554-560.
25. Rademakers R, Stewart H, Dejesus-Hernandez M, Krieger C, Graff-Radford N, et al. (2010) Fus gene mutations in familial and sporadic amyotrophic lateral sclerosis. Muscle Nerve 42: 170-176.
26. Tateishi T, Hokonohara T, Yamasaki R, Miura S, Kikuchi H, et al. (2010) Multiple system degeneration with basophilic inclusions in Japanese ALS patients with FUS mutation. Acta Neuropathol 119: 355-364.
27. Suzuki N, Aoki M, Warita H, Kato M, Mizuno H, et al. (2010) FALS with FUS mutation in Japan, with early onset, rapid progress and basophilic inclusion. J Hum Genet 55: 252-254.
28. Mackenzie IR, Rademakers R, Neumann M, (2010) TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol 9: 995-1007.
29. Benajiba L, Le Ber I, Camuzat A, Lacoste M, Thomas-Anterion C, et al. (2009) TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann Neurol 65: 470-473.
30. Borroni B, Bonvicini C, Alberici A, Buratti E, Agosti C, et al. (2009) Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease. Hum Mutat 30: E974-983.
31. Sleegers K, Cruts M, Van Broeckhoven C, (2010) Molecular pathways of frontotemporal lobar degeneration. Annu Rev Neurosci 33: 71-88.
32. Van Langenhove T, van der Zee J, Sleegers K, Engelborghs S, Vandenberghe R, et al. (2010) Genetic contribution of FUS to frontotemporal lobar degeneration. Neurology 74: 366-371.
33. Deng HX, Zhai H, Bigio EH, Yan J, Fecto F, et al. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann Neurol 67: 739-748.
34. Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, et al. (2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 61: 427-434.
35. Ling SC, Albuquerque CP, Han JS, Lagier-Tourenne C, Tokunaga S, et al. ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc Natl Acad Sci U S A.
36. Kim SH, Shanware NP, Bowler MJ, Tibbetts RS, (2010) Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA. J Biol Chem 285: 34097-34105.
37. Lanson NA Jr, Maltare A, King H, Smith R, Kim JH, et al. (2011) A Drosophila model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43. Hum Mol Genet.
38. Fiesel FC, Voigt A, Weber SS, Van den Haute C, Waldenmaier A, et al. (2010) Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6. EMBO J 29: 209-221.
39. Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, et al. (2011) Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci 14: 459-468.
40. Ayala YM, Zago P, D'Ambrogio A, Xu YF, Petrucelli L, et al. (2008) Structural determinants of the cellular localization and shuttling of TDP-43. J Cell Sci 121: 3778-3785.
41. Buratti E, Baralle FE, (2010) The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. RNA Biol 7: 420-429.
42. Park J, Lee SB, Lee S, Kim Y, Song S, et al. (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441: 1157-1161.
43. Pallanck L, Greenamyre JT, (2006) Neurodegenerative disease: pink, parkin and the brain. Nature 441: 1058.
44. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304: 1158-1160.
45. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, et al. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392: 605-608.
46. Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466: 1069-1075.
47. Valdmanis PN, Meijer IA, Reynolds A, Lei A, MacLeod P, et al. (2007) Mutations in the KIAA0196 gene at the SPG8 locus cause hereditary spastic paraplegia. Am J Hum Genet 80: 152-161.
48. Laird AS, Van Hoecke A, De Muynck L, Timmers M, Van den Bosch L, et al. Progranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathy. PLoS ONE 5: e13368 doi:10.1371/journal.pone.0013368.
49. Gros-Louis F, Kriz J, Kabashi E, McDearmid J, Millecamps S, et al. (2008) Als2 mRNA splicing variants detected in KO mice rescue severe motor dysfunction phenotype in Als2 knock-down zebrafish. Hum Mol Genet 17: 2691-2702.
50. Kabashi E, Lin L, Tradewell ML, Dion PA, Bercier V, et al. (2010) Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum Mol Genet 19: 671-683.
51. Simpson CL, Lemmens R, Miskiewicz K, Broom WJ, Hansen VK, et al. (2009) Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration. Hum Mol Genet 18: 472-481.
52. Ramesh T, Lyon AN, Pineda RH, Wang C, Janssen PM, et al. A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease. Dis Model Mech 3: 652-662.
53. Kabashi E, Champagne N, Brustein E, Drapeau P, In the swim of things: recent insights to neurogenetic disorders from zebrafish. Trends Genet.
54. Ito D, Seki M, Tsunoda Y, Uchiyama H, Suzuki N, (2011) Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS. Ann Neurol 69: 152-162.
55. Gal J, Zhang J, Kwinter DM, Zhai J, Jia H, et al. (2010) Nuclear localization sequence of FUS and induction of stress granules by ALS mutants. Neurobiol Aging.
56. Tan AY, Manley JL, (2009) The TET family of proteins: functions and roles in disease. J Mol Cell Biol 1: 82-92.
57. Ticozzi N, Vance C, Leclerc AL, Keagle P, Glass JD, et al. (2011) Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis. Am J Med Genet B Neuropsychiatr Genet.
58. Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, et al. (1996) Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 13: 43-47.
59. Bosco DA, Lemay N, Ko HK, Zhou H, Burke C, et al. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum Mol Genet 19: 4160-4175.
60. Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, et al. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J Neurosci 30: 639-649.
61. Dormann D, Rodde R, Edbauer D, Bentmann E, Fischer I, et al. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J 29: 2841-2857.
62. Liu-Yesucevitz L, Bilgutay A, Zhang YJ, Vanderwyde T, Citro A, et al. Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS ONE 5: e3250 doi:10.1371/journal.pone.0013250.
63. Colombrita C, Zennaro E, Fallini C, Weber M, Sommacal A, et al. (2009) TDP-43 is recruited to stress granules in conditions of oxidative insult. J Neurochem 111: 1051-1061.
64. Kryndushkin D, Wickner RB, Shewmaker F, FUS/TLS forms cytoplasmic aggregates, inhibits cell growth and interacts with TDP-43 in a yeast model of amyotrophic lateral sclerosis. Protein Cell 2: 223-236.
65. Fushimi K, Long C, Jayaram N, Chen X, Li L, et al. Expression of human FUS/TLS in yeast leads to protein aggregation and cytotoxicity, recapitulating key features of FUS proteinopathy. Protein Cell 2: 141-149.
66. Lagier-Tourenne C, Polymenidou M, Cleveland DW, (2010) TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet 19: R46-64.
67. Zhang YJ, Xu YF, Dickey CA, Buratti E, Baralle F, et al. (2007) Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. J Neurosci 27: 10530-10534.
68. Rademakers R, Eriksen JL, Baker M, Robinson T, Ahmed Z, et al. (2008) Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum Mol Genet 17: 3631-3642.
69. Kleinberger G, Wils H, Ponsaerts P, Joris G, Timmermans JP, et al. (2010) Increased caspase activation and decreased TDP-43 solubility in progranulin knockout cortical cultures. J Neurochem 115: 735-747.
70. Ritson GP, Custer SK, Freibaum BD, Guinto JB, Geffel D, et al. TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97. J Neurosci 30: 7729-7739.
71. Gitcho MA, Strider J, Carter D, Taylor-Reinwald L, Forman MS, et al. (2009) VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death. J Biol Chem 284: 12384-12398.
72. Johnson JO, Mandrioli J, Benatar M, Abramzon Y, Van Deerlin VM, et al. (2010) Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS. Neuron 68: 857-864.
73. Jowett T, (2001) Double in situ hybridization techniques in zebrafish. Methods 23: 345-358.